pyridoxine-dependent epilepsy; neonatal epileptic encephalopathy; pyridoxine-5'-phosphate oxidase deficiency; PNPO deficiency
Jump to navigation
Jump to search
Pathology
- combination of various seizure types
Genetics
Clinical manifestations
- generally occurs in the 1st hours of life
- unresponsive to standard anticonvulsants
Management
- unresponsive to anticonvulsants
- responds only to administration of:
- pyridoxine hydrochloride (if defect is in ALDH7A1)
- pyridoxal-5'-phosphate (if defect is in PNPO)